TMDX FY 2021 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

FY 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$30M+18.0% YoY

Gross Profit

$21M69.9% margin

Operating Income

-$39M-130.3% margin

Net Income

-$44M-146.1% margin

EPS (Diluted)

$-1.60

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$32M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$135M

Total Liabilities

$67M

Stockholders' Equity

$68M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$26M	+18.0%
Gross Profit	$21M	$17M	+27.2%
Operating Income	-$39M	-$26M	-49.4%
Net Income	-$44M	-$29M	-53.8%